1. Home
  2. LGND vs KWR Comparison

LGND vs KWR Comparison

Compare LGND & KWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • KWR
  • Stock Information
  • Founded
  • LGND 1987
  • KWR 1918
  • Country
  • LGND United States
  • KWR United States
  • Employees
  • LGND N/A
  • KWR N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • KWR Major Chemicals
  • Sector
  • LGND Health Care
  • KWR Industrials
  • Exchange
  • LGND Nasdaq
  • KWR Nasdaq
  • Market Cap
  • LGND 2.0B
  • KWR 1.8B
  • IPO Year
  • LGND 1992
  • KWR 1985
  • Fundamental
  • Price
  • LGND $108.55
  • KWR $104.23
  • Analyst Decision
  • LGND Strong Buy
  • KWR Strong Buy
  • Analyst Count
  • LGND 7
  • KWR 4
  • Target Price
  • LGND $144.67
  • KWR $157.75
  • AVG Volume (30 Days)
  • LGND 116.1K
  • KWR 194.4K
  • Earning Date
  • LGND 05-08-2025
  • KWR 05-01-2025
  • Dividend Yield
  • LGND N/A
  • KWR 1.86%
  • EPS Growth
  • LGND N/A
  • KWR 3.95
  • EPS
  • LGND N/A
  • KWR 6.51
  • Revenue
  • LGND $167,133,000.00
  • KWR $1,839,686,000.00
  • Revenue This Year
  • LGND $16.47
  • KWR $2.57
  • Revenue Next Year
  • LGND $19.44
  • KWR $4.77
  • P/E Ratio
  • LGND N/A
  • KWR $15.98
  • Revenue Growth
  • LGND 27.28
  • KWR N/A
  • 52 Week Low
  • LGND $69.17
  • KWR $95.91
  • 52 Week High
  • LGND $129.90
  • KWR $197.03
  • Technical
  • Relative Strength Index (RSI)
  • LGND 53.94
  • KWR 37.88
  • Support Level
  • LGND $101.24
  • KWR $98.26
  • Resistance Level
  • LGND $111.39
  • KWR $109.26
  • Average True Range (ATR)
  • LGND 5.67
  • KWR 6.03
  • MACD
  • LGND 0.82
  • KWR 0.50
  • Stochastic Oscillator
  • LGND 84.05
  • KWR 50.03

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

Share on Social Networks: